title: Keeping kidneys safe: the pharmacist's role in NSAID avoidance in high-risk patients.
abstract: OBJECTIVE
  To provide information on the role of pharmacists in nonsteroidal anti-inflammatory drug (NSAID) avoidance in high-risk patients.
  
  
  CONCLUSIONS
  Nonprescription analgesics such as ibuprofen and naproxen are widely used by Americans. These nonsteroidal anti-inflammatory drugs (NSAIDs) are available in large quantities in pharmacies and also in wholesale stores, gas stations, and convenience stores. In addition, more than 111 million people use prescription NSAIDs each year, including many older Americans. NSAIDs may seem innocuous, but they carry a significant risk of disrupting blood flow to the kidneys and thus precipitating acute kidney injury (AKI). Episodes of AKI can lead to costly hospitalizations and long-term consequences such as new-onset chronic kidney disease (CKD) or more rapid progression of existing CKD. Most cases of NSAID-induced AKI can be avoided by recognizing high-risk patients and counseling them on appropriate use of these medications. Community pharmacy-based NSAID counseling and education at the point of prescription dispensing or nonprescription purchase could complement and augment NSAID-induced AKI education provided by other members of the health care team to high-risk patients.
  
  
  CONCLUSIONS
  NSAID use is widespread and severely compromises effective renal perfusion in high-risk patients. The community pharmacist can play a pivotal role in NSAID avoidance education to prevent potential episodes of AKI that have long-term consequences for patients.
authors.forename: Amy Barton
authors.initials: AB
authors.lastname: Pai
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002983:Clinical Competence; D003376:Counseling; D004346:Drug Information Services; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000503:physiopathology; D004366:Nonprescription Drugs / Q000009:adverse effects*; D010353:Patient Education as Topic; D010595:Pharmacists; D024382:Professional Role; D065840:Protective Factors; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D004366:Nonprescription Drugs